ENTRY       D09930                      Drug
NAME        Mavrilimumab (USAN/INN)
FORMULA     C6706H10438N1762O2104S54
EXACT_MASS  151044.8863
MOL_WEIGHT  151138.6849
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGASVKV SCKVSGYTLT ELSIHWVRQA PGKGLEWMGG FDPEENEIVY
            AQRFQGRVTM TEDTSTDTAY MELSSLRSED TAVYYCAIVG SFSPLTLGLW GQGTMVTVSS
            ASTKGPSVFP LAPCSRSTSE STAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
            GLYSLSSVVT VPSSSLGTKT YTCNVDHKPS NTKVDKRVES KYGPPCPSCP APEFLGGPSV
            FLFPPKPKDT LMISRTPEVT CVVVDVSQED PEVQFNWYVD GVEVHNAKTK PREEQFNSTY
            RVVSVLTVLH QDWLNGKEYK CKVSNKGLPS SIEKTISKAK GQPREPQVYT LPPSQEEMTK
            NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSRL TVDKSRWQEG
            NVFSCSVMHE ALHNHYTQKS LSLSLGK
            (Light chain)
            QSVLTQPPSV SGAPGQRVTI SCTGSGSNIG APYDVSWYQQ LPGTAPKLLI YHNNKRPSGV
            PDRFSGSKSG TSASLAITGL QAEDEADYYC ATVEAGLSGS VFGGGTKLTV LGQPKAAPSV
            TLFPPSSEEL QANKATLVCL ISDFYPGAVT VAWKADSSPV KAGVETTTPS KQSNNKYAAS
            SYLSLTPEQW KSHRSYSCQV THEGSTVEKT VAPTECS
            (Disulfide bridge: H22-H96, H147-H203, H261-H321, H367-H425, H226-H'226, H229-H'229, L22-L90, L139-L198, H134-L216)
  TYPE      Peptide
EFFICACY    Antirheumatic, Anti-GMCSF receptor antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of rheumatoid arthritis
TARGET      CSF2RA (GMCSFR, CD116) [HSA:1438] [KO:K05066]
  PATHWAY   hsa04060(1438)  Cytokine-cytokine receptor interaction
            hsa04630(1438)  JAK-STAT signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               CSF and other factor receptors
                CSF2RA (GMCSFR, CD116)
                 D09930  Mavrilimumab (USAN/INN)
DBLINKS     CAS: 1085337-57-0
            PubChem: 124490622
///
